The Ultrashort Peptide OW: A New Antibiotic Adjuvant

• Published in: Current pharmaceutical biotechnology Vol. 20; no. 9; p. 745
• Main Authors: Al Tall, Yara, Abualhaijaa, Ahmad, Qaoud, Mohammed T, Alsaggar, Mohammad, Masadeh, Majed, Alzoubi, Karem H
• Format: Journal Article
• Language: English
• Published: Netherlands 01.01.2019
• Subjects: Adjuvants, Pharmaceutic - chemistry; Adjuvants, Pharmaceutic - pharmacology; Anti-Bacterial Agents - chemistry; Anti-Bacterial Agents - pharmacology; Biofilms - drug effects; Drug Resistance, Multiple, Bacterial - drug effects; Drug Synergism; HEK293 Cells; Humans; Methicillin-Resistant Staphylococcus aureus - drug effects; Microbial Sensitivity Tests; Oligopeptides - chemistry; Oligopeptides - pharmacology; Pseudomonas aeruginosa - drug effects; synergism; Antimicrobial resistance; antibiotic adjuvant; MIC; hemolytic assay; ultrashort peptide
• ISSN: 1873-4316
• DOI: 10.2174/1389201020666190618111252

The over use of current antibiotics and low discovery rate of the new ones are leading to rapid development of multidrug-resistant pathogens worldwide. Antimicrobial peptides have shown promising results against multidrug-resistant bacteria. To investigate the antimicrobial activity of a new ultrashort hexapeptide (OW). The OW hexapeptide was designed and tested against different strains of bacteria with different levels of sensitivity. Bacterial susceptibility assays were performed according to the guidelines of the Clinical and Laboratory Institute (CLSI). The synergistic studies were then conducted using the Checkerboard assay. This was followed by checking the hemolytic effect of the hexapeptide against human blood cells and Human Embryonic Kidney cell line (HEK293). Finally, the antibiofilm activities of the hexapeptide were studied using the Biofilm Calgary method. Synergistic assays showed that OW has synergistic effects with antibiotics of different mechanisms of action. It showed an outstanding synergism with Rifampicin against methicillin resistant Staphylococcus aureus; ΣFIC value was 0.37, and the MIC value of Rifampicin was decreased by 85%. OW peptide also displayed an excellent synergism with Ampicillin against multidrug-resistant Pseudomonas aeruginosa, with ΣFIC value of less than 0.38 and a reduction of more than 96% in the MIC value of Ampicillin. This study introduced a new ultrashort peptide (OW) with promising antimicrobial potential in the management of drug-resistant infectious diseases as a single agent or in combination with commonly used antibiotics. Further studies are needed to investigate the exact mechanism of action of these peptides.